<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.4 20241031//EN" "JATS-archivearticle1-4-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.4" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8004854</journal-id><journal-id journal-id-type="pubmed-jr-id">536</journal-id><journal-id journal-id-type="nlm-ta">Am J Infect Control</journal-id><journal-id journal-id-type="iso-abbrev">Am J Infect Control</journal-id><journal-title-group><journal-title>American journal of infection control</journal-title></journal-title-group><issn pub-type="ppub">0196-6553</issn><issn pub-type="epub">1527-3296</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40518051</article-id><article-id pub-id-type="pmc">13464689</article-id><article-id pub-id-type="doi">10.1016/j.ajic.2025.06.005</article-id><article-id pub-id-type="manuscript">NIHMS2199443</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Outbreak of New Delhi metallo-&#x003b2;-lactamase carbapenemase-producing <italic toggle="yes">Pseudomonas aeruginosa</italic> infections in a Southern California hospital</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Garrigues</surname><given-names>Jacob M.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="FN1" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name><surname>Gray</surname><given-names>Hannah K.</given-names></name><degrees>PhD, D(ABMM)</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="FN1" ref-type="author-notes">1</xref><xref rid="FN2" ref-type="author-notes">2</xref></contrib><contrib contrib-type="author"><name><surname>Ison</surname><given-names>Ricardo P.</given-names></name><degrees>BS</degrees><xref rid="A3" ref-type="aff">c</xref><xref rid="FN1" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name><surname>Uslan</surname><given-names>Daniel Z.</given-names></name><degrees>MD, MBA</degrees><xref rid="A3" ref-type="aff">c</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Amorce</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez-Ferrer</surname><given-names>Shekina</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Trejo</surname><given-names>Marisol</given-names></name><degrees>BS</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Zhuo</surname><given-names>Ran</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Matysiak Match</surname><given-names>Colette J.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Ulloa</surname><given-names>Erlinda R.</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">e</xref><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Bhaurla</surname><given-names>Sandeep</given-names></name><degrees>MPH, CIC</degrees><xref rid="A7" ref-type="aff">g</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Vanessa</given-names></name><degrees>MPH, CIC</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Parti</surname><given-names>Urvashi</given-names></name><degrees>MPH, CIC</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Sandoval</surname><given-names>Tessa</given-names></name><degrees>MPH, CIC</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Turay</surname><given-names>Sebora</given-names></name><degrees>MS, CIC</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Walton</surname><given-names>Shaunt&#x000e9;</given-names></name><degrees>MS, CIC</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Prabaker</surname><given-names>Kavitha</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">c</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Garner</surname><given-names>Omai B.</given-names></name><degrees>PhD, D(ABMM)</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Chandrasekaran</surname><given-names>Sukantha</given-names></name><degrees>PhD, D(ABMM)</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Green</surname><given-names>Nicole M.</given-names></name><degrees>PhD, D(ABMM)</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Shangxin</given-names></name><degrees>PhD, D(ABMM)</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Public Health Laboratories, County of Los Angeles Department of Public Health, Downey, CA</aff><aff id="A2"><label>b</label>Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA</aff><aff id="A3"><label>c</label>Clinical Epidemiology &#x00026; Infection Prevention, UCLA Health, Los Angeles, CA</aff><aff id="A4"><label>d</label>Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA</aff><aff id="A5"><label>e</label>Division of Infectious Diseases, Children&#x02019;s Hospital of Orange County, Orange, CA</aff><aff id="A6"><label>f</label>Department of Pediatrics, University of California Irvine School of Medicine, Irvine, CA</aff><aff id="A7"><label>g</label>Acute Communicable Disease Control, County of Los Angeles Department of Public Health, Los Angeles, CA</aff><author-notes><corresp id="CR1"><label>*</label>Address correspondence to Nicole M. Green, PhD, D(ABMM), Los Angeles County Department of Public Health, 12750 Erickson Avenue, Downey, CA 90242 or Shangxin Yang, PhD, D(ABMM), UCLA Clinical Microbiology Laboratory, 11633 San Vicente Blvd, Los Angeles, CA 90049. <email>nicgreen@ph.lacounty.gov</email> (N. Green), <email>shangxinyang@mednet.ucla.edu</email> (S. Yang).</corresp><fn fn-type="equal" id="FN1"><label>1</label><p id="P1">The authors have contributed equally.</p></fn><fn fn-type="current-aff" id="FN2"><label>2</label><p id="P2">Current affiliation: Division of Disease Control &#x02013; Public Health Laboratory, NYC Department of Health and Mental Hygiene, New York, NY.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>6</day><month>8</month><year>2026</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>13</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>8</month><year>2026</year></pub-date><volume>53</volume><issue>9</issue><fpage>977</fpage><lpage>984</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> ).</license-p></license></permissions><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">Carbapenemase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> (CP-CRPA) is a major public health threat due to limited treatment options and high transmissibility. Though widespread globally, few instances of locally transmitted New Delhi metallo-&#x003b2;-lactamase (NDM)-producing CP-CRPA have been documented in the United States. Here, a cluster of locally transmitted NDM-1 CP-CRPA infections in Southern California is reported.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">Epidemiologic investigations involving both patient screening and environmental surveillance by microbiological culture, carbapenemase testing, and bacterial whole-genome sequencing were conducted.</p></sec><sec id="S3"><title>Results:</title><p id="P5">Through extensive epidemiologic investigations, a sink environmental reservoir was identified. A genetically unique strain of NDM-CRPA was identified to be transmitted among seven patients in a single hospital over the course of 1.5 years. Changes in antimicrobial resistance genes harbored by a mobile genetic element were identified between the index and later cases, and the gene encoding NDM-1 resided within a mobile genetic element on the chromosome displaying evidence of widespread transmission between different species. Several interventions were implemented, including sink P-trap replacement and disinfectant against <italic toggle="yes">Pseudomonas</italic> biofilms. No additional cases were identified after the interventions.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P6">Implementation of real-time pathogen surveillance enabled effective response to an ongoing outbreak that involved environmental sampling, microbiological testing, whole-genome sequencing, facility management, and updated infection prevention policies.</p></sec></abstract><kwd-group><kwd>NDM</kwd><kwd>Sink</kwd><kwd>P-trap</kwd><kwd>Genomic surveillance</kwd><kwd>Whole-genome sequencing</kwd></kwd-group></article-meta></front><body><sec id="S5"><title>BACKGROUND</title><p id="P7">Carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> (CRPA) accounts for approximately 10% to 30% of clinically isolated <italic toggle="yes">P aeruginosa</italic> strains in the United States.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Carbapenemase production represents only a fraction of this resistance, with the Centers for Disease Control and Prevention reporting 1,530 carbapenemase-producing CRPA (CP-CRPA) among more than 68,000 CRPA isolates collected between 2017 and 2022.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Within CP-CRPA in the United States, Verona Integron-encoded Metallo-&#x003b2;-lactamase (VIM) is the predominant carbapenemase detected. While the New Delhi metallo-&#x003b2;-lactamase (NDM) is prevalent in Asia, Europe, and the Middle East, it remains rare in the United States, with few cases of autochthonous transmission. NDM-producing CP-CRPA can be especially challenging to treat, with ~30% treatment failure.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> One such case of NDM-producing CP-CRPA in Southern California is thought to be an endemic strain, given the patient&#x02019;s lack of international travel and genetic dissimilarity to global strains.<sup><xref rid="R4" ref-type="bibr">4</xref></sup></p><p id="P8">The transmission of carbapenemase genes within and between bacterial populations is of urgent concern, making infection prevention critical to stop the spread of these isolates. A number of outbreaks of CP-CRPA have been reported in health facilities in the United States, including an outbreak of imipenemase metallo-&#x003b2;-lactamase (IMP)-producing strains in an intensive care unit in Idaho,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> a cluster of VIM-producing strains in a skilled nursing facility in Chicago,<sup><xref rid="R6" ref-type="bibr">6</xref></sup> and a recent report of NDM-1 isolates in Texas, starting with a travel-associated index case.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Certain &#x0201c;high-risk strains&#x0201d; of <italic toggle="yes">P aeruginosa</italic>, such as ST235, ST111, and ST233, are particularly concerning due to their extensive drug resistance (XDR) and carriage of carbapenemase genes. These sequence types, found globally, can harbor both chromosomal and plasmid carbapenemase genes and are associated with over 60 different &#x003b2;-lactamases.<sup><xref rid="R8" ref-type="bibr">8</xref></sup></p><p id="P9">Here, an outbreak involving local transmission of NDM-producing CP-CRPA in a Southern California hospital is described. Epidemiologic investigations and genomic sequencing identified a sink as the environmental reservoir.</p></sec><sec id="S6"><title>METHODS</title><sec id="S7"><title>Environmental testing and patient surveillance</title><p id="P10">A total of 72 environmental samples were collected during the outbreak investigations. Forty-six patients were screened as part of two separate point prevalence surveys. Each patient was screened once, except for one individual with a prolonged admission who was tested during both surveys. The point prevalence surveys were conducted as part of the routine outbreak response protocol to assess potential transmission and identify additional cases.</p></sec><sec id="S8"><title>Laboratory testing of surveillance and clinical isolates</title><p id="P11"><italic toggle="yes">P aeruginosa</italic> isolates from clinical specimens exhibiting elevated carbapenem minimum inhibitory concentrations, as determined by microbroth dilution following Clinical and Laboratory Standards Institute (CLSI) guidelines, were screened for carbapenemase production. The NG-test CARBA 5 immunochromatographic lateral flow assay (Hardy Diagnostics) was utilized to detect five carbapenemases: VIM, IMP, NDM, KPC, and OXA-48-like. Between April 2023 and September 2024, eight <italic toggle="yes">P aeruginosa</italic> isolates tested positive for NDM production via this methodology and were included in this study. Clinical isolates were also tested for cefiderocol and imipenem/relebactam susceptibility using Kirby-Bauer disk diffusion according to CLSI guidelines. The environmental surveillance samples (surface swabs) and patient surveillance samples (rectal swabs) were collected using eSwab (Becton Dickinson) and plated on the carbapenem-resistant gram-negative bacteria surveillance culture medium ChromID Carba agar (BioMerieux). Isolates that grew from the surveillance culture were subcultured onto TSA II 5% sheep blood agar (Becton Dickinson) with a meropenem disk to further select for pure carbapenem-resistant isolates, which were then identified by VITEK matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy system (BioMerieux) and tested for carbapenemase production using the Hardy NG-test CARBA 5 assay. Throughout this study, isolate 1 denotes the isolate collected from patient 1, while isolate 2 denotes the isolate collected from patient 2, etc.</p></sec><sec id="S9"><title>Whole-genome sequencing</title><p id="P12">Genomic DNA was extracted from bacterial isolates using the Qiagen DNeasy Blood and Tissue extraction kit. For short-read sequencing, libraries were prepared using the Illumina DNA Library Prep kit, followed by paired-end sequencing on a MiSeq instrument using Illumina MiSeq Reagent Kits v2 (500 cycles). For long-read sequencing, libraries were prepared using the Oxford Nanopore Technologies (ONT) Rapid Barcoding Kit and sequenced on an ONT GridION instrument using R10.4 flowcells. Base calling was performed using onboard ONT MinKnow software with the high-accuracy base calling model.</p></sec><sec id="S10"><title>Genome assembly and genomic analyses</title><p id="P13">For short-read sequences, de novo assemblies were generated with the TheiaProk_Illumina_PHB v2.2.1 workflow on Terra.bio using default settings.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> kSNP3.0 was used to determine core-genome single-nucleotide polymorphism (SNP) differences and construct a maximum-parsimony phylogenetic tree with default settings. Phylogenetic tree visualization was performed using Iroki.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> PubMLST<sup><xref rid="R11" ref-type="bibr">11</xref></sup> was used to determine multilocus sequence type, and antimicrobial resistance (AMR) genes and point mutations were identified using AMRFinderPlus v3.12.8 with database v2024-05-02.2.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup></p><p id="P14">Hybrid de novo assemblies combining both short and long reads were generated for isolates obtained from patients 1, 4, and 5 using the TheiaProk_ONT_PHB v2.0.1 workflow on Terra.bio with default settings. Annotations of genes and some noncoding elements (including <italic toggle="yes">attI</italic> sites) for hybrid assemblies were produced using Bakta v1.5.1 with database v4.0,<sup><xref rid="R13" ref-type="bibr">13</xref></sup> while AMR genes were identified using AMRFinderPlus. In instances where Bakta and AMRFinderPlus annotations conflicted, AMRFinderPlus annotations superseded. Identification of <italic toggle="yes">attC</italic> sites was performed using HattCI v1.0b with default settings<sup><xref rid="R14" ref-type="bibr">14</xref></sup>; only <italic toggle="yes">attC</italic> sites identified with a Viterbi score &#x0003e; 1 were considered. Identification of genomic islands containing putative mobile genetic elements (MGEs) was performed using IslandViewer 4.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> NCBI BLAST (megablast against database nt) using default parameters<sup><xref rid="R16" ref-type="bibr">16</xref></sup> was used to identify homologous regions in reference genomes.</p></sec><sec id="S11"><title>Research ethics</title><p id="P15">This study received an IRB exemption; approval was given to perform a chart review of all patients under investigation.</p></sec></sec><sec id="S12"><title>RESULTS</title><p id="P16">Eight cases of NDM-producing CP-CRPA were identified in the same Southern California hospital: one from April 2023, five from June through August 2023, one from April 2024, and the last one from September 2024 (<xref rid="T1" ref-type="table">Table 1</xref>). The index case (patient 1) in this cluster was previously described<sup><xref rid="R4" ref-type="bibr">4</xref></sup> and reported recent travel to Hawaii. Patient 2 received recent medical care in Iran, and no other patients reported recent travel outside of the area. Two patients (patients 2 and 6) did not receive any antimicrobial treatment due to asymptomatic bacteriuria, two recovered (patients 1 and 7) after treatment with cefiderocol. Three patients (patients 4, 5, and 8) succumbed due to underlying comorbidities.</p><p id="P17">Notably, patient 3 was admitted for extracorporeal membrane oxygenation support and initially treated with cefiderocol for NDM-producing CRPA identified in a sputum culture. After stabilizing, the patient was transferred to their home institution for management of acute myeloid leukemia. During this time, the patient developed necrotic skin lesions secondary to calciphylaxis, which became superinfected with multidrug-resistant organisms, including a now pan-resistant NDM-producing CRPA. The patient received bacteriophage therapy, compassionate use of cefepime-zidebactam, and sodium thiosulfate for calciphylaxis. The patient has since fully recovered.</p><p id="P18">Isolates from these NDM-producing CP-CRPA cases were obtained from various sources, including urine, respiratory tract, blood, and peritoneal fluid (<xref rid="T1" ref-type="table">Table 1</xref>). Consistent with the production of NDM &#x003b2;-lactamase, phenotypic susceptibility testing (<xref rid="T2" ref-type="table">Table 2</xref>) found that all isolates were resistant to &#x003b2;-lactam antibiotics, including carbapenems. All isolates included in this study were susceptible to cefiderocol, and those tested for colistin susceptibility exhibited intermediate results.</p><p id="P19">In response to the identification of NDM-producing CP-CRPA in patients 4 and 5, the first epidemiologic investigation was launched. Commonalities between staff, procedures, equipment, and patient care locations were investigated. From this, it was determined that respiratory therapists (RTs) were shared between four patients, and registered nurses between two patients. All patients were either on a ventilator or had a tracheostomy at the time of their positive culture. However, no RT equipment or machines were identified as shared between patients, and single-use nebulizers and airway clearance devices were strictly used before disposal. Additionally, no shared water sources were identified. Extensive environmental sampling of the RT equipment reprocessing area, including sinks, drains, and work surfaces, did not yield any <italic toggle="yes">P aeruginosa</italic>. As a precaution, the sink in the RT equipment reprocessing area was replaced.</p><p id="P20">Following identification of the seventh case in April 2024, a point prevalence study was conducted in the unit. While several patients had <italic toggle="yes">P aeruginosa</italic> identified on rectal culture, none were carbapenemase producers. Additional environmental sampling revealed growth of <italic toggle="yes">P aeruginosa</italic> in multiple sinks and P-traps, but none were NDM CP-CRPA. After the eighth case, a third investigation was launched, and extensive environmental sampling ultimately detected two NDM-positive environmental <italic toggle="yes">P aeruginosa</italic> isolates from the drain and P-trap of a sink in an intensive care unit room that previously housed patients 1 and 8.</p><p id="P21">To determine the relatedness of NDM CP-CRPA isolates from patient and environmental sources, whole-genome sequencing (WGS) using Illumina was performed and the resulting genome assemblies were compared. All isolates were typed as ST235 and harbored the <italic toggle="yes">bla</italic><sub>NDM-1</sub> gene. Nucleotide-level comparison of all assemblies revealed that isolate 2 differed by over 1,000 SNPs, indicating it was unrelated to the other isolates (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). After excluding isolate 2, the remaining patient isolates (from patients 1, 3, 4, 5, 6, 7, and 8) and both environmental isolates (sink drain and P-trap) differed by only zero to 14 SNPs, suggesting close relatedness (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). Comparison to other sequenced isolates available at NCBI using Pathogen Detection<sup><xref rid="R17" ref-type="bibr">17</xref></sup> revealed that environmental isolates, and those from patients 1, 3, 4, 5, 6, 7, and 8, formed a distinct cluster, separate from other isolates (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). In contrast, isolate 2 did not cluster with any of the other isolates (data not shown). Notably, the isolate collected from patient 8 was most similar to the environmental and the index patient isolates, clustering phylogenetically with both (<xref rid="F1" ref-type="fig">Fig. 1A</xref>,<xref rid="F1" ref-type="fig">B</xref>), consistent with the epidemiologic link of the two patients who stayed in the same room with the contaminated sink, albeit 1.5 years apart. These results suggest a high likelihood that the NDM-producing CP-CRPA was introduced by the index patient and subsequently spread to the other six patients over the course of 1.5 years, and a contaminated sink played an important role in its transmission.</p><p id="P22">WGS revealed comprehensive AMR gene profiles for individual isolates, consistent with the XDR phenotypes observed. All isolates contained several AMR genes in addition to <italic toggle="yes">bla</italic><sub>NDM-1</sub> (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Notably, isolate 2 harbored aminoglycoside resistance genes <italic toggle="yes">aph(3</italic>&#x02032;<italic toggle="yes">)-IIb</italic> and <italic toggle="yes">aph(3</italic>&#x02032;<italic toggle="yes">)-VI</italic>, &#x003b2;-lactamase genes <italic toggle="yes">bla</italic><sub>PME-1</sub>, <italic toggle="yes">bla</italic><sub>PDC-35</sub>, and <italic toggle="yes">bla</italic><sub>OXA-488</sub>, the fosfomycin resistance gene <italic toggle="yes">fosA</italic>, phenicol resistance genes <italic toggle="yes">catB7</italic> and <italic toggle="yes">floR2</italic>, the sulfonamide resistance gene <italic toggle="yes">sul1</italic>, and the tetracycline resistance gene <italic toggle="yes">tet(G)</italic>. Additionally, isolate 2 contained an <italic toggle="yes">oprD (W339*)</italic> mutation associated with &#x003b2;-lactam resistance, as well as <italic toggle="yes">gyrA(T83I)</italic> and <italic toggle="yes">parC(S87W)</italic> mutations associated with quinolone resistance. Outbreak isolates shared similar AMR gene profiles, including <italic toggle="yes">aph(3</italic>&#x02032;<italic toggle="yes">)-IIb</italic> and <italic toggle="yes">aph(3</italic>&#x02032;<italic toggle="yes">)-VIa, bla</italic><sub>PDC-35</sub> and <italic toggle="yes">bla</italic><sub>OXA-488</sub>, <italic toggle="yes">fosA</italic>, the fluoroquinolone resistance gene <italic toggle="yes">crpP</italic>, as well as <italic toggle="yes">catB7</italic>, <italic toggle="yes">floR2</italic>, <italic toggle="yes">sul1</italic>, and <italic toggle="yes">tet(G)</italic>. All outbreak isolates also carried an ambiguous <italic toggle="yes">bla</italic><sub>PME</sub> gene, with the closest match being <italic toggle="yes">bla</italic><sub>PME-1</sub>, a truncated form of the &#x003b2;-lactamase gene <italic toggle="yes">bla</italic><sub>KBL</sub>, and a penicillin-binding protein 3 gene mutation <italic toggle="yes">ftsI(R504C)</italic> associated with &#x003b2;-lactam resistance. Furthermore, the <italic toggle="yes">gyrA(T83I)</italic> mutation was observed in all outbreak isolates. However, there were some differences observed between outbreak isolates: environmental isolates and those from patients 1 and 8 contained the aminoglycoside resistance genes <italic toggle="yes">aac(6</italic>&#x02032;<italic toggle="yes">)-Ib4</italic> and <italic toggle="yes">aadA1</italic>, the phenicol resistance gene <italic toggle="yes">catB3</italic>, and the &#x003b2;-lactamase gene <italic toggle="yes">bla</italic><sub>OXA-10</sub>, while isolates from patients 3, 4, 5, 6, and 7 contained the aminoglycoside resistance gene <italic toggle="yes">aadA6</italic>. These results demonstrate that isolate 2 had a unique AMR gene profile compared with the other isolates, further supporting its unrelatedness. Moreover, the observed AMR gene differences between environmental isolates and those from patients 1 and 8 compared with the remaining isolates suggest that genomic changes emerged over the course of the outbreak.</p><p id="P23">One potential explanation for the AMR gene differences observed between outbreak isolates may be explained by gene residence within active MGEs. To enable full resolution of MGEs and infer MGE activities occurred during this outbreak, ONT long-read WGS was performed using select isolates and combined with short reads to generate hybrid assemblies. Isolate 1 from the index case contained a class 1 integron nested within a putative Tn<italic toggle="yes">3</italic> family transposon with <italic toggle="yes">sul1</italic> and <italic toggle="yes">qacE</italic>&#x00394;<italic toggle="yes">1</italic> in its 3&#x02032; conserved region. Within its variable region, this integron had an array of three gene cassettes (<xref rid="F2" ref-type="fig">Fig. 2</xref>): the first cassette harbored <italic toggle="yes">aac(6</italic>&#x02032;<italic toggle="yes">)-Ib4</italic>, the second <italic toggle="yes">catB3</italic>, and the third <italic toggle="yes">bla</italic><sub>OXA-10</sub> and <italic toggle="yes">aadA1</italic> in different reading frames. In isolates 4 and 5 collected from later cases, a class 1 integron located at the same genomic position contained only one gene cassette that harbored <italic toggle="yes">aadA6</italic>. Taken together, these observations suggest that the variability in AMR genes and phenotypic susceptibility observed within this outbreak was due to gene cassette switching in an integron that remained in place.</p><p id="P24">We also explored the intraspecific transmissibility of the <italic toggle="yes">bla</italic><sub>NDM-1</sub>-containing MGE. Hybrid genome assemblies of Southern California CP-CRPA isolates revealed that <italic toggle="yes">bla</italic><sub>NDM-1</sub> in outbreak isolates was located within a chromosomal array of AMR genes containing <italic toggle="yes">sul1</italic>, three copies of <italic toggle="yes">bla</italic><sub>PME-1</sub>, <italic toggle="yes">aph(3</italic>&#x02032;<italic toggle="yes">)-VIa</italic>, <italic toggle="yes">floR2</italic>, and <italic toggle="yes">tet(G)</italic>, as well as truncated forms of <italic toggle="yes">bla</italic><sub>KBL</sub> and <italic toggle="yes">ble</italic><sub>MBL</sub>, which was not detected in short-read-based assemblies. This array was located within the "cargo2" region of a previously described MGE, integrative and conjugative element (ICE) <italic toggle="yes">6660</italic><sup><xref rid="R18" ref-type="bibr">18</xref></sup> (<xref rid="F3" ref-type="fig">Fig. 3</xref>). This ICE<italic toggle="yes">6660</italic> cargo2 region resembled others found in sequenced isolates available at NCBI, including <italic toggle="yes">P aeruginosa</italic> from South Korea, <italic toggle="yes">P juntendi</italic> from China, and <italic toggle="yes">Aeromonas caviae</italic> from Vietnam (<xref rid="F3" ref-type="fig">Fig. 3</xref>), suggesting widespread exchange across species and even genera.</p></sec><sec id="S13"><title>DISCUSSION</title><p id="P25">Sequencing revealed close genetic similarity (0-14 SNPs) between all isolates, except isolate 2, which was quickly determined to be unrelated. Given the high prevalence of NDM-1 CP-CRPA in Iran and the Middle East,<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> this isolate may be associated with the patient&#x02019;s extensive health care history in the region prior to visiting the Southern California facility. A prior study demonstrated that the index isolate, isolate 1, was distinct from previously described global isolates, indicating it was likely a unique domestic strain.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> The subsequent isolates are also likely descendants of this same strain, given a <italic toggle="yes">P aeruginosa</italic> mutation rate of between 6 &#x000d7; 10<sup>&#x02212;4</sup> and 1.6 &#x000d7; 10<sup>&#x02212;1</sup> mutations per genome per generation.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> Indeed, phylogenetic analyses using the National Center for Biotechnology Information (NCBI) Pathogen Detection Isolates Browser<sup><xref rid="R17" ref-type="bibr">17</xref></sup> demonstrated that all the Southern California isolates distinctly cluster together relative to other isolates available at NCBI, indicating a hospital outbreak that was originated from an index patient without international travel history, and transmitted nosocomially including via a contaminated sink. The outbreak progressed slowly, and cases were identified sporadically, spanning 1.5 years. The insidious nature of the transmission, despite exhaustive investigation and numerous negative environmental cultures, made the investigations challenging. The source was not identified until the third intensive culture&#x02013;based investigation with dozens of environmental samples tested.</p><p id="P26">MGEs such as plasmids, transposons, and ICEs are major contributors to the spread of AMR genes through horizontal gene transfer.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Notably, the NDM-1 gene is located on the chromosome and not on a plasmid, which makes this strain inherently resistant to carbapenems. No plasmids were detected in isolates from this outbreak, while multiple AMR genes were found within putative MGEs inserted into the bacterial chromosome. Several AMR genes, including <italic toggle="yes">bla</italic><sub>NDM-1</sub>, were found in an array within the cargo2 region of an ICE<italic toggle="yes">6660</italic> element; 3 copies of <italic toggle="yes">bla</italic><sub>PME-1</sub> were present. This region is similar to other ICE<italic toggle="yes">6660</italic> cargo2 regions found in clinical <italic toggle="yes">P aeruginosa</italic> and <italic toggle="yes">P juntendi</italic> isolates collected in South Korea and China, respectively, as well as an environmental <italic toggle="yes">A caviae</italic> isolate collected from wastewater in Vietnam, suggesting widespread horizontal gene transfer. Chromosomal insertions suggest AMR genes in the Southern California CP-CRPA strain may be more stable than if they were located on plasmids, which heightens the epidemiologic significance of this XDR pathogen.</p><p id="P27">The observed differences in detected AMR genes between genetically related isolates suggested some AMR genes were lost and acquired within this cluster. Integrons are genetic elements containing a variable region flanked by <italic toggle="yes">attI</italic> and <italic toggle="yes">attC</italic> recombination sites allowing for the capture and exchange of different gene cassettes, and can be carried by transposons integrated into the genome or plasmids.<sup><xref rid="R23" ref-type="bibr">23</xref></sup> The isolate from the index case within this outbreak had a class 1 integron containing three AMR gene cassettes harboring <italic toggle="yes">aac (6</italic>&#x02032;<italic toggle="yes">)-Ib4</italic>, <italic toggle="yes">catB3</italic>, <italic toggle="yes">bla</italic><sub>OXA-10</sub>, and <italic toggle="yes">aadA1</italic>, while isolates from later cases had only one AMR gene cassette with <italic toggle="yes">aadA6</italic>. As these integrons were inserted at the same location on the bacterial chromosome, these findings suggest that AMR gene cassettes were swapped during the course of this outbreak, providing an example of AMR gene dynamics that can occur in related isolates. Therefore, phenotypic susceptibility results should be interpreted with caution for outbreak investigations.</p><p id="P28">Nosocomial spread of <italic toggle="yes">Pseudomonas</italic> via sinks has been demonstrated in numerous studies, as the bacteria are well-adapted to thrive in moist environments and can form a biofilm extending from the P-trap to the drain.<sup><xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R27" ref-type="bibr">27</xref></sup> Based on our investigations and findings, several interventions were implemented, including: (1) replacing the sink P-trap in the affected room; (2) weekly application of an EPA-registered disinfectant against <italic toggle="yes">Pseudomonas</italic> biofilms (Virasept, Ecolab, Inc) in all sinks; (3) staff education; (4) installation of splash guards in the medication preparation areas; (5) reminders to staff to keep patient care supplies out of sink splash zones; (6) adjusting faucets so they do not pour directly on the drain; (7) regular audits of environmental services cleaning; and (8) use of the CDC Water Infection Control Risk Assessment (WICRA) for Healthcare Settings to evaluate and prioritize water risk interventions. Follow-up environmental cultures obtained six weeks later, did not detect NDM CP-CRPA. No additional cases were identified as of the submission of this paper (February 24, 2025).</p><p id="P29">While the contaminated sink was strongly implicated in the transmission of NDM-producing CP-CRPA to patients 1 and 8, not all cases in this outbreak could be directly epi-linked to that environmental reservoir. For instance, patients 4 and 5 were identified on the same date (July 7, 2023). Although they were not housed in the same room or hospitalized concurrently, our review of care patterns revealed overlapping involvement of respiratory therapy and nursing staff, as well as shared use of procedural rooms for similar interventions. These observations raise the possibility of indirect cross-transmission via health care personnel or contaminated procedural environments. While causality cannot be confirmed retrospectively, such overlaps represent plausible transmission routes that merit consideration in outbreak investigations. This highlights the complexity of health care-associated pathogen transmission and underscores the importance of evaluating both environmental and operational factors in prolonged outbreak responses. Contaminated sink drains have been clearly linked to numerous outbreaks of infections due to gram-negative bacilli, including <italic toggle="yes">Pseudomonas</italic>, and have received increasing attention as an environmental reservoir.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Colonized drains can result in intermittent dispersal of organisms to other environmental surfaces such as countertops, to health care worker or patient hands or clothing, or medical equipment.<sup><xref rid="R29" ref-type="bibr">29</xref>-<xref rid="R31" ref-type="bibr">31</xref></sup> In outbreaks similar to this one, prolonged durations have been noted lasting many months or years. Longer patient length of stay may be a risk factor for patient acquisition.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> Once established, eradication of sink drain colonization is challenging due to persistence of organisms in biofilms and inadequate contact time achieved by disinfectants when poured into a sink drain. In this outbreak, the lengthy time in-between cases and initially negative environmental cultures highlight the challenges with outbreak investigation of potentially contaminated sinks. Intensive water management interventions, such as application of EPA-registered disinfectant with biofilm claims, may be required to control transmission.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup> Sink drain and wastewater plumbing should be included in health care water infection control risk assessments and investigated as a potential source of outbreaks due to gram-negative bacilli.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup></p></sec><sec id="S14"><title>CONCLUSIONS</title><p id="P30">NDM-producing CRPA poses an extremely high risk to patients, especially those with reduced immune function and extended hospitalization. Use of WGS contributed to the rapid detection, characterization, and subsequent infection control response, which is critical to curbing the spread of these organisms in health care settings. We demonstrate that a unique strain of NDM CP-CRPA was transmitted among seven patients in a single hospital over the course of 1.5 years, with two cases linked to a contaminated sink. Implementation of real-time pathogen surveillance enabled effective response to an ongoing outbreak that involved environmental sampling, microbiological testing, WGS, facility management, and updated infection prevention policies.</p></sec></body><back><ack id="S15"><title>Acknowledgements</title><p id="P31">We thank the staff in the UCLA Clinical Microbiology Laboratory and Molecular Microbiology and Pathogen Genomics (MMPG) Laboratory for their technical support. We also thank the Molecular Epidemiology and Sequencing Units at Los Angeles County Public Health Laboratories for sequencing of isolates. Special thanks to the Los Angeles County Department of Public Health for their assistance with the investigation, including Kelsey Oyong, Jehan Mephors, Kezia Coster and Moon Kim in the Acute Communicable Disease Control Program.</p><sec id="S16"><title>Funding:</title><p id="P32">Los Angeles County Public Health Laboratories are supported by the Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases cooperative agreement of the Centers for Disease Control and Prevention (grants 6 NU50CK000498 and NU51CK000357).</p></sec></ack><fn-group><fn id="FN3"><p id="P33">Availability of data and materials: Raw sequencing data and assembled genomes were deposited at NCBI Sequence Read Archive (SRA) and GenBank, respectively, with the following BioSamples: Patient 1&#x02014;SAMN37517877, Patient 2&#x02014;SAMN37517876, Patient 3&#x02014;SAMN43961544, Patient 4&#x02014;SAMN36985094, Patient 5&#x02014;SAMN36985093, Patient 6&#x02014;SAMN3751787, Patient 7&#x02014;SAMN41673794, and Patient 8&#x02014;SAMN44246514.</p></fn><fn fn-type="COI-statement" id="FN4"><p id="P34">Conflicts of interest: None to report.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Tenover</surname><given-names>FC</given-names></name>, <name><surname>Nicolau</surname><given-names>DP</given-names></name>, <name><surname>Gill</surname><given-names>CM</given-names></name>. <article-title>Carbapenemase-producing <italic toggle="yes">Pseudomonas aeruginosa</italic>-an emerging challenge</article-title>. <source>Emerg Microbes Infect</source>. <year>2022</year>;<volume>11</volume>:<fpage>811</fpage>&#x02013;<lpage>814</lpage>.<pub-id pub-id-type="pmid">35240944</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="webpage"><collab>CDC</collab>. <source>Antibiotic Resistance &#x00026; Patient Safety Portal (AR&#x00026;PSP) AR Lab Network Data</source>. Accessed on: <date-in-citation>02/15/2024</date-in-citation>.. &#x02329;<ext-link xlink:href="https://arpsp.cdc.gov/" ext-link-type="uri">https://arpsp.cdc.gov/</ext-link>&#x0232a;.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Buehrle</surname><given-names>DJ</given-names></name>, <name><surname>Shields</surname><given-names>RK</given-names></name>, <name><surname>Clarke</surname><given-names>LG</given-names></name>, <etal/>
<article-title>Carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> bacteremia: risk factors for mortality and microbiologic treatment failure</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2017</year>;<volume>61</volume>:<fpage>e01243</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">27821456</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Gray</surname><given-names>HK</given-names></name>, <name><surname>Beaird</surname><given-names>OE</given-names></name>, <name><surname>Smith</surname><given-names>EA</given-names></name>, <etal/>
<article-title>Domestically acquired NDM-1-producing <italic toggle="yes">Pseudomonas aeruginosa</italic>, Southern California, USA, 2023</article-title>. <source>Emerg Infect Dis</source>. <year>2023</year>;<volume>29</volume>:<fpage>2382</fpage>&#x02013;<lpage>2385</lpage>.<pub-id pub-id-type="pmid">37877613</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Cahill</surname><given-names>ME</given-names></name>, <name><surname>Jaworski</surname><given-names>M</given-names></name>, <name><surname>Harcy</surname><given-names>V</given-names></name>, <etal/>
<article-title>Cluster of carbapenemase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> among patients in an adult intensive care unit - Idaho, 2021-2022</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2023</year>;<volume>72</volume>:<fpage>844</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">37535466</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Clegg</surname><given-names>WJ</given-names></name>, <name><surname>Pacilli</surname><given-names>M</given-names></name>, <name><surname>Kemble</surname><given-names>SK</given-names></name>, <etal/>
<article-title>Notes from the field: large cluster of verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates colonizing residents at a skilled nursing facility - Chicago, Illinois, November 2016-March 2018</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2018</year>;<volume>67</volume>:<fpage>1130</fpage>&#x02013;<lpage>1131</lpage>.<pub-id pub-id-type="pmid">30307908</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Sopirala</surname><given-names>MM</given-names></name>, <name><surname>Hartless</surname><given-names>K</given-names></name>, <name><surname>Reid</surname><given-names>S</given-names></name>, <etal/>
<article-title>Investigation of the first reported outbreak of New Delhi metallo-beta-lactamase-1-producing <italic toggle="yes">Pseudomonas aeruginosa</italic> in Texas</article-title>. <source>Antimicrob Steward Healthc Epidemiol</source>. <year>2024</year>;<volume>3</volume>:<fpage>e251</fpage>.<pub-id pub-id-type="pmid">38178880</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Del Barrio-Tofino</surname><given-names>E</given-names></name>, <name><surname>Lopez-Causape</surname><given-names>C</given-names></name>, <name><surname>Oliver</surname><given-names>A</given-names></name>. <article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> epidemic high-risk clones and their association with horizontally-acquired beta-lactamases: 2020 update</article-title>. <source>Int J Antimicrob Agents</source>. <year>2020</year>;<volume>56</volume>:<fpage>106196</fpage>.<pub-id pub-id-type="pmid">33045347</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Libuit</surname><given-names>KG</given-names></name>, <name><surname>Doughty</surname><given-names>EL</given-names></name>, <name><surname>Otieno</surname><given-names>JR</given-names></name>, <etal/>
<article-title>Accelerating bioinformatics implementation in public health</article-title>. <source>Microb Genom</source>. <year>2023</year>;<volume>9</volume>:<fpage>mgen001051</fpage>.<pub-id pub-id-type="pmid">37428142</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>RM</given-names></name>, <name><surname>Harrison</surname><given-names>AO</given-names></name>, <name><surname>McAllister</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Iroki: automatic customization and visualization of phylogenetic trees</article-title>. <source>PeerJ</source>. <year>2020</year>;<volume>8</volume>:<fpage>e8584</fpage>.<pub-id pub-id-type="pmid">32149022</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Jolley</surname><given-names>KA</given-names></name>, <name><surname>Bray</surname><given-names>JE</given-names></name>, <name><surname>Maiden</surname><given-names>MCJ</given-names></name>. <article-title>Open-access bacterial population genomics: BIGSdb software, the <ext-link xlink:href="http://PubMLST.org" ext-link-type="uri">PubMLST.org</ext-link> website and their applications</article-title>. <source>Wellcome Open Res</source>. <year>2018</year>;<volume>3</volume>:<fpage>124</fpage>.<pub-id pub-id-type="pmid">30345391</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Feldgarden</surname><given-names>M</given-names></name>, <name><surname>Brover</surname><given-names>V</given-names></name>, <name><surname>Gonzalez-Escalona</surname><given-names>N</given-names></name>, <etal/>
<article-title>AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>:<fpage>12728</fpage>.<pub-id pub-id-type="pmid">34135355</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Schwengers</surname><given-names>O</given-names></name>, <name><surname>Jelonek</surname><given-names>L</given-names></name>, <name><surname>Dieckmann</surname><given-names>MA</given-names></name>, <etal/>
<article-title>Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification</article-title>. <source>Microb Genom</source>. <year>2021</year>;<volume>7</volume>:<fpage>000685</fpage>.<pub-id pub-id-type="pmid">34739369</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Pereira</surname><given-names>MB</given-names></name>, <name><surname>Wallroth</surname><given-names>M</given-names></name>, <name><surname>Kristiansson</surname><given-names>E</given-names></name>, <name><surname>Axelson-Fisk</surname><given-names>M</given-names></name>. <article-title>HattCI: fast and accurate attC site identification using Hidden Markov Models</article-title>. <source>J Comput Biol</source>. <year>2016</year>;<volume>23</volume>:<fpage>891</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="pmid">27428829</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Bertelli</surname><given-names>C</given-names></name>, <name><surname>Laird</surname><given-names>MR</given-names></name>, <name><surname>Williams</surname><given-names>KP</given-names></name>, <etal/>
<article-title>IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>:<fpage>W30</fpage>&#x02013;<lpage>W35</lpage>.<pub-id pub-id-type="pmid">28472413</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>M</given-names></name>, <name><surname>Zaretskaya</surname><given-names>I</given-names></name>, <name><surname>Raytselis</surname><given-names>Y</given-names></name>, <etal/>
<article-title>NCBI BLAST: a better web interface</article-title>. <source>Nucleic Acids Res</source>. <year>2008</year>;<volume>36</volume>:<fpage>W5</fpage>&#x02013;<lpage>W9</lpage>.<pub-id pub-id-type="pmid">18440982</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="webpage"><collab>NCBI Health</collab>. <source>NCBI Pathogen Detection</source>. Accessed <date-in-citation>May 30, 2024</date-in-citation>. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pathogens/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pathogens/</ext-link>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Urbanowicz</surname><given-names>P</given-names></name>, <name><surname>Izdebski</surname><given-names>R</given-names></name>, <name><surname>Baraniak</surname><given-names>A</given-names></name>, <etal/>
<article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> with NDM-1, DIM-1 and PME-1 beta-lactamases, and RmtD3 16S rRNA methylase, encoded by new genomic islands</article-title>. <source>J Antimicrob Chemother</source>. <year>2019</year>;<volume>74</volume>:<fpage>3117</fpage>&#x02013;<lpage>3119</lpage>.<pub-id pub-id-type="pmid">31211367</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Rad</surname><given-names>ZR</given-names></name>, <name><surname>Rad</surname><given-names>ZR</given-names></name>, <name><surname>Goudarzi</surname><given-names>H</given-names></name>, <etal/>
<article-title>Detection of New Delhi metallo-&#x003b2;-lactamase-1 among isolated from adult and pediatric patients in Iranian hospitals</article-title>. <source>Gene Rep</source>. <year>2021</year>;<volume>23</volume>:<fpage>101152</fpage>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Shahin</surname><given-names>M</given-names></name>, <name><surname>Ahmadi</surname><given-names>A</given-names></name>. <article-title>Molecular characterization of NDM-1-producing <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates from hospitalized patients in Iran</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. <year>2021</year>;<volume>20</volume>:<fpage>76</fpage>.<pub-id pub-id-type="pmid">34732199</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Dettman</surname><given-names>JR</given-names></name>, <name><surname>Sztepanacz</surname><given-names>JL</given-names></name>, <name><surname>Kassen</surname><given-names>R</given-names></name>. <article-title>The properties of spontaneous mutations in the opportunistic pathogen <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title>. <source>BMC Genomics</source>. <year>2016</year>;<volume>17</volume>:<fpage>27</fpage>.<pub-id pub-id-type="pmid">26732503</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Partridge</surname><given-names>SR</given-names></name>, <name><surname>Kwong</surname><given-names>SM</given-names></name>, <name><surname>Firth</surname><given-names>N</given-names></name>, <name><surname>Jensen</surname><given-names>SO</given-names></name>. <article-title>Mobile genetic elements associated with antimicrobial resistance</article-title>. <source>Clin Microbiol Rev</source>. <year>2018</year>;<volume>31</volume>:<fpage>e00088</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">30068738</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>Y</given-names></name>, <name><surname>Bao</surname><given-names>X</given-names></name>, <name><surname>Ji</surname><given-names>L</given-names></name>, <etal/>
<article-title>Resistance integrons: class 1, 2 and 3 integrons</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. <year>2015</year>;<volume>14</volume>:<fpage>45</fpage>.<pub-id pub-id-type="pmid">26487554</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Scharer</surname><given-names>V</given-names></name>, <name><surname>Meier</surname><given-names>MT</given-names></name>, <name><surname>Schuepbach</surname><given-names>RA</given-names></name>, <etal/>
<article-title>An intensive care unit outbreak with multi-drug-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> - spotlight on sinks</article-title>. <source>J Hosp Infect</source>. <year>2023</year>;<volume>139</volume>:<fpage>161</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">37343769</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>A</given-names></name>, <name><surname>Thure</surname><given-names>K</given-names></name>, <name><surname>Tobey</surname><given-names>K</given-names></name>, <etal/>
<article-title>Containment of a verona integron-encoded metallo-beta-lactamase-producing <italic toggle="yes">Pseudomonas aeruginosa</italic> outbreak associated with an Acute Care Hospital Sink-Tennessee, 2018-2020</article-title>. <source>Open Forum Infect Dis</source>. <year>2023</year>;<volume>10</volume>:<fpage>ofad194</fpage>.<pub-id pub-id-type="pmid">37180588</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Catho</surname><given-names>G</given-names></name>, <name><surname>Martischang</surname><given-names>R</given-names></name>, <name><surname>Boroli</surname><given-names>F</given-names></name>, <etal/>
<article-title>Outbreak of <italic toggle="yes">Pseudomonas aeruginosa</italic> producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care</article-title>. <source>Crit Care</source>. <year>2021</year>;<volume>25</volume>:<fpage>301</fpage>.<pub-id pub-id-type="pmid">34412676</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>Z</given-names></name>, <name><surname>Hu</surname><given-names>B</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <etal/>
<article-title>Sources of sporadic <italic toggle="yes">Pseudomonas aeruginosa</italic> colonizations/infections in surgical ICUs: association with contaminated sink trap</article-title>. <source>J Infect Chemother</source>. <year>2016</year>;<volume>22</volume>:<fpage>450</fpage>&#x02013;<lpage>455</lpage>.<pub-id pub-id-type="pmid">27184934</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Volling</surname><given-names>C</given-names></name>, <name><surname>Ahangari</surname><given-names>N</given-names></name>, <name><surname>Bartoszko</surname><given-names>JJ</given-names></name>, <etal/>
<article-title>Are sink drainage systems a reservoir for hospital-acquired Gammaproteobacteria colonization and infection? A systematic review</article-title>. <source>Open Forum Infect Dis</source>. <year>2021</year>;<volume>8</volume>:<fpage>ofaa590</fpage>.<pub-id pub-id-type="pmid">33553469</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Kotay</surname><given-names>S</given-names></name>, <name><surname>Chai</surname><given-names>W</given-names></name>, <name><surname>Guilford</surname><given-names>W</given-names></name>, <etal/>
<article-title>Spread from the sink to the patient: in situ study using green fluorescent protein (GFP)-expressing <italic toggle="yes">Escherichia coli</italic> to model bacterial dispersion from hand-washing sink-trap reservoirs</article-title>. <source>Appl Environ Microbiol</source>. <year>2017</year>;<volume>83</volume>:<fpage>e03327</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">28235877</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Hajar</surname><given-names>Z</given-names></name>, <name><surname>Mana</surname><given-names>TSC</given-names></name>, <name><surname>Cadnum</surname><given-names>JL</given-names></name>, <name><surname>Donskey</surname><given-names>CJ</given-names></name>. <article-title>Dispersal of gram-negative bacilli from contaminated sink drains to cover gowns and hands during hand washing</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2019</year>;<volume>40</volume>:<fpage>460</fpage>&#x02013;<lpage>462</lpage>.<pub-id pub-id-type="pmid">30767838</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Varghese</surname><given-names>MM</given-names></name>, <name><surname>Torres-Teran</surname><given-names>MM</given-names></name>, <name><surname>Greentree</surname><given-names>DH</given-names></name>, <etal/>
<article-title>What is the optimal frequency of sink drain decontamination with a foam disinfectant?</article-title>
<source>Infect Control Hosp Epidemiol</source>. <year>2024</year>;<volume>45</volume>:<fpage>1143</fpage>&#x02013;<lpage>1145</lpage>.<pub-id pub-id-type="pmid">38659124</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Kizny Gordon</surname><given-names>AE</given-names></name>, <name><surname>Mathers</surname><given-names>AJ</given-names></name>, <name><surname>Cheong</surname><given-names>EYL</given-names></name>, <etal/>
<article-title>The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections-a systematic review of the literature</article-title>. <source>Clin Infect Dis</source>. <year>2017</year>;<volume>64</volume>:<fpage>1435</fpage>&#x02013;<lpage>1444</lpage>.<pub-id pub-id-type="pmid">28200000</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1.</label><caption><p id="P35">Single-nucleotide polymorphism (SNP) differences, phylogenetic analyses, and antimicrobial resistance (AMR) gene content of Southern California New Delhi metallo-&#x003b2;-lactamase (NDM) carbapenemase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> (CP-CRPA) isolates. (A) Core-genome SNP differences between Southern California NDM CP-CRPA isolates collected from patients and environmental sources. Isolate 1 was collected from patient 1, while isolate 2 was collected from patient 2, etc. Red denotes a high number of SNP differences, while green represents a low number of SNP differences and isolates likely to be related. SNP differences for isolate 2 were obtained by comparing to all other isolates; pairwise SNP differences for all other isolates were obtained after excluding isolate 2 to maximize core-genome size and the number of detected SNPs. (B) Maximum-parsimony phylogenetic tree based on SNP differences between Southern California NDM CP-CRPA isolates collected from patients and environmental sources as well as similar isolates available at NCBI (SRR28910554, SRR28741925, and SRR24510026). Isolate 2 was excluded due to a high number of SNP differences. Phylogenetic tree was rooted using another similar isolate as an outgroup (SRR13414623, not shown). Scale bar represents SNP distance. (C) AMR genes detected in short-read-based genome assemblies obtained from Southern California NDM CP-CRPA isolates. Isolates were collected from patients and environmental sources. Blue indicates the respective gene was detected, while gray indicates the gene was not detected. The <italic toggle="yes">bla</italic><sub>NDM-1</sub> gene is labeled in red. Antimicrobial drug classes are shown.</p></caption><graphic xlink:href="nihms-2199443-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2.</label><caption><p id="P36">Class 1 integron with antimicrobial resistance (AMR) gene cassette differences between Southern California NDM CP-CRPA isolates. Composition of a class 1 integron containing AMR gene cassettes found in the index and later case isolates. Protein-coding genes are depicted with arrows pointing in the 5&#x02032; to 3&#x02032; direction. AMR genes are labeled and shown in green, while transposase genes are in blue and other types of genes are in yellow. 5&#x02032; and 3&#x02032; conserved regions are highlighted (5&#x02032;-CS and 3&#x02032;-CS, respectively), which contain the <italic toggle="yes">intl1</italic>, <italic toggle="yes">sul1</italic>, <italic toggle="yes">qacE</italic>&#x00394;<italic toggle="yes">1</italic>, and <italic toggle="yes">orf5</italic> genes. Positions of <italic toggle="yes">attI</italic> and <italic toggle="yes">attC</italic> recombination sites are denoted. Gray shading represents regions shared between isolates. Scale bar represents genomic distance. CP-CRPA, carbapenemase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic>; NDM, New Delhi metallo-&#x003b2;-lactamase.</p></caption><graphic xlink:href="nihms-2199443-f0002" position="float"/></fig><fig position="float" id="F3"><label>Fig. 3.</label><caption><p id="P37">Antimicrobial resistance (AMR) gene arrays carried by ICE<italic toggle="yes">6660</italic>-like elements found in Southern California New Delhi metallo-&#x003b2;-lactamase (NDM) carbapenemase-producing carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> (CP-CRPA) isolates and other unrelated isolates. Genes detected in cargo2 variable regions nested within ICE<italic toggle="yes">6660</italic>-like elements identified in hybrid genome assemblies obtained from Southern California NDM CP-CRPA isolates and other publicly available assemblies. Protein-coding genes are represented with arrows pointing in the 5&#x02032; to 3&#x02032; direction. AMR genes are labeled and shown in green, while transposase genes are in blue and other types of genes are in yellow. Depicted in red is a DNA methyltransferase gene where the cargo2 variable region has been inserted. Gray shading represents regions shared between isolates. Scale bar represents genomic distance.</p></caption><graphic xlink:href="nihms-2199443-f0003" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p id="P38">Clinical history of Southern California NDM-producing <italic toggle="yes">Pseudomonas aeruginosa</italic> cases</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Patient</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate<break/>recovery date</th><th align="left" valign="top" rowspan="1" colspan="1">Age</th><th align="left" valign="top" rowspan="1" colspan="1">Travel history</th><th align="left" valign="top" rowspan="1" colspan="1">Significant comorbidities and medical<break/> history</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate source</th><th align="left" valign="top" rowspan="1" colspan="1">Treatment</th><th align="left" valign="top" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">04/07/2023</td><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1">Domestic travel (Hawaii)</td><td align="left" valign="top" rowspan="1" colspan="1">End-stage cardiac disease, cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (ECMO), and orthotopic heart transplant (OHT)</td><td align="left" valign="top" rowspan="1" colspan="1">Urine</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol</td><td align="left" valign="top" rowspan="1" colspan="1">Discharged</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">06/04/2023</td><td align="left" valign="top" rowspan="1" colspan="1">84</td><td align="left" valign="top" rowspan="1" colspan="1">Iran, extended medical care</td><td align="left" valign="top" rowspan="1" colspan="1">Parkinson&#x02019;s disease, hip fracture, and replacement</td><td align="left" valign="top" rowspan="1" colspan="1">Urine</td><td align="left" valign="top" rowspan="1" colspan="1">Untreated</td><td align="left" valign="top" rowspan="1" colspan="1">Discharged</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">07/04/2023</td><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Acute myeloid leukemia, acute hypoxic respiratory failure requiring ECMO</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory, BAL</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol, ceftazidime-avibactam, aztreonam, azithromycin, tobramycin, cefepime-zidebactam, and phage therapy</td><td align="left" valign="top" rowspan="1" colspan="1">Discharged</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">07/07/2023</td><td align="left" valign="top" rowspan="1" colspan="1">74</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Prostate cancer, sepsis, enterocolitis, <italic toggle="yes">Clostridium difficile</italic> infection, severe acute kidney injury, aspiration pneumonia, acute hypoxemic respiratory failure, pulmonary edema, and multiorgan dysfunction syndrome</td><td align="left" valign="top" rowspan="1" colspan="1">Blood</td><td align="left" valign="top" rowspan="1" colspan="1">Untreated</td><td align="left" valign="top" rowspan="1" colspan="1">Deceased</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">07/07/2023</td><td align="left" valign="top" rowspan="1" colspan="1">76</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Papillary thyroid cancer, radiation therapy, tracheal hemorrhage, and gangrenous cholecystitis</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory, tracheal aspirate</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol</td><td align="left" valign="top" rowspan="1" colspan="1">Deceased</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">08/01/2023</td><td align="left" valign="top" rowspan="1" colspan="1">67</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Nonischemic cardiomyopathy, atrial fibrillation, cardiogenic shock, and OHT</td><td align="left" valign="top" rowspan="1" colspan="1">Urine</td><td align="left" valign="top" rowspan="1" colspan="1">Untreated</td><td align="left" valign="top" rowspan="1" colspan="1">Discharged</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">04/24/2024</td><td align="left" valign="top" rowspan="1" colspan="1">54</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Heart failure, ECMO, OHT, and seroma at the ECMO cannulation</td><td align="left" valign="top" rowspan="1" colspan="1">Body fluid, abdomen</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol</td><td align="left" valign="top" rowspan="1" colspan="1">Discharged</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">09/23/2024</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">None noted</td><td align="left" valign="top" rowspan="1" colspan="1">Metastatic thymoma, sterno-thoracotomy with radical thymectomy, en bloc extrapleural pneumonectomy, pericardial reconstruction, pneumothorax with chest tube placement, ECMO, and ventilator-associated pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory, tracheal aspirate</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol</td><td align="left" valign="top" rowspan="1" colspan="1">Deceased</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P39"><italic toggle="yes">NDM</italic>, New Delhi metallo-&#x003b2;-lactamase.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2</label><caption><p id="P40">Antibiotic susceptibility phenotypes of Southern California NDM-positive <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates from patients</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Drug class</th><th align="left" valign="top" rowspan="1" colspan="1">Drug</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 1</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 2</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 3</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 4</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 5</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 6</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 7</th><th align="left" valign="top" rowspan="1" colspan="1">Isolate 8</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Aminoglycoside</td><td align="left" valign="top" rowspan="1" colspan="1">Amikacin</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Gentamicin</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Tobramycin</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td colspan="9" align="left" valign="top" rowspan="1">&#x003b2;-lactam</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cephalosporin</td><td align="left" valign="top" rowspan="1" colspan="1">Cefepime</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Ceftazidime</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x003b2;-lactam/&#x003b2;-lactamase inhibitor</td><td align="left" valign="top" rowspan="1" colspan="1">Amox/Clav</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Ceftaz/Avi</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Cefto/Tazo</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Imi/Rele</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Pip/Tazo</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carbapenem</td><td align="left" valign="top" rowspan="1" colspan="1">Imipenem</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Meropenem</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Siderophore cephalosporin</td><td align="left" valign="top" rowspan="1" colspan="1">Cefiderocol</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td><td align="left" valign="top" rowspan="1" colspan="1">Susceptible</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fluoroquinolone</td><td align="left" valign="top" rowspan="1" colspan="1">Ciprofloxacin</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Polymyxin</td><td align="left" valign="top" rowspan="1" colspan="1">Colistin</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Not tested</td><td align="left" valign="top" rowspan="1" colspan="1">Not tested</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sulfonamide</td><td align="left" valign="top" rowspan="1" colspan="1">Trimeth/Sulf</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td><td align="left" valign="top" rowspan="1" colspan="1">Resistant</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P41"><italic toggle="yes">Amox/Clav</italic>, Amoxicillin/Clavulanic acid; <italic toggle="yes">Ceftaz/Avi</italic>, Ceftazidime/Avibactam; <italic toggle="yes">Cefto/Tazo</italic>, Ceftolozane/Tazobactam; <italic toggle="yes">Imi/Rele</italic>, Imipenem/Relebactam; <italic toggle="yes">NDM</italic>, New Delhi metallo-&#x003b2;-lactamase; <italic toggle="yes">Pip/Tazo</italic>, Piperacillin/Tazobactam; <italic toggle="yes">Trimeth/Sulf</italic>, Trimethoprim/Sulfonamide.</p></fn></table-wrap-foot></table-wrap></floats-group></article>